Pfizer sues Teva for infringing Zyvox patent

Claiming patent infringement, Pfizer Inc. has filed a complaint in the US District Court in Delaware, requesting an injunction to block Teva Pharmaceutical Industries Ltd from selling a generic form of its Zyvox antibiotic. The move follows Teva’s filing an abbreviated new drug application with the US Food and Drug Administration, seeking regulatory approval, which Pfizer claims is patent infringement. Zyvox is used to treat pneumonia and skin infections and has global sales of about $1.1 billion a year. The Teva generic would threaten Zyvox’s US sales, which totaled about $575 million. The Zyvox patent may be renewed until 2014, unless Teva can somehow invalidate it.

This entry was posted on Sunday, January 24th, 2010 at 8:14 am and is filed under Intellectual Property, Israel, Israel Related, Teva, drugs, infringement, pharmaceuticals. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

One Response to “Pfizer sues Teva for infringing Zyvox patent”

  1. Pfizer sues Teva for infringing Zyvox patent | Hadron blog says:
    January 24, 2010 at 5:13 pm

    [...] Source Tags: delaware, dispute, FDA, infringement, intellectual property, invalidation, Lawsuit, patent, patent infringement, pfizer, pneumonia, skin infections, sue, sued, teva, zyvox. [...]

    Reply

Leave a Reply